{
    "Trade/Device Name(s)": [
        "Virtuoso\u2122 System for IHC HER2 (4B5)",
        "Ventana Virtuoso\u2122 System for HER2 (4B5)"
    ],
    "Submitter Information": "Ventana Digital Pathology",
    "510(k) Number": "K111543",
    "Predicate Device Reference 510(k) Number(s)": [
        "K080654",
        "K092333"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OEO",
        "NOT"
    ],
    "Summary Letter Date": "September 27, 2011",
    "Summary Letter Received Date": "September 28, 2011",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR864.1860"
    ],
    "Regulation Name(s)": [
        "Immunohistochemistry reagents and kits"
    ],
    "Analyte Class(es)": [
        "anatomic pathology"
    ],
    "Analyte(s)": [
        "HER2 protein"
    ],
    "Specimen Type(s)": [
        "Formalin-fixed, paraffin-embedded tissue"
    ],
    "Specimen Container(s)": [
        "Glass slide"
    ],
    "Instrument(s)/Platform(s)": [
        "iScan slide scanner",
        "Computer",
        "Monitor",
        "Keyboard",
        "Mouse"
    ],
    "Method(s)/Technology(ies)": [
        "Digital pathology",
        "Image analysis",
        "Immunohistochemistry (IHC)"
    ],
    "Methodologies": [
        "Digital read",
        "Image analysis",
        "Semi-quantitative measurement"
    ],
    "Submission Type(s)": [
        "System",
        "Analyzer",
        "Software",
        "Accessory"
    ],
    "Document Summary": "FDA 510(k) summary for Ventana Virtuoso\u2122 System for IHC HER2 (4B5) digital pathology/image analysis aiding semi-quantitative HER2 measurement in FFPE tissues using IHC.",
    "Indications for Use Summary": "Aids pathologists in detecting and semi-quantitatively measuring HER2 protein in formalin-fixed, paraffin-embedded normal and neoplastic tissue; intended to assist in assessing breast cancer patients for HERCEPTIN\u00ae (Trastuzumab) treatment.",
    "fda_folder": "Hematology"
}